Dr. Luis Amselem earned his degree in Medicine and Surgery from the Autonomous University of Barcelona (U.A.B.) and completed his residency at Valle Hebrón Hospital in Barcelona. He subsequently began a residency program in Ophthalmology at the General University Hospital of Valencia, where he earned the title of Specialist in Ophthalmology.

During his residency, he showed a particular interest in the subspecialty of retina, completing fellowships at the Mayo Clinic in Rochester, Minnesota (USA), where he was IRB (Institutional Review Board) certified for research at the Mayo Clinic and participated in numerous research projects, including studies on AMD (Age-Related Macular Degeneration), retinal vascular diseases (diabetic retinopathy, arterial and venous occlusions, etc.), and ocular oncology.

Dr. Amselem has published numerous articles as first author in the most prestigious international and national journals in his field, and is a regular speaker at national and international conferences on the retina.

Since 2008, his biography has been included in Marquis’s prestigious publication “Who’s Who in the World,” which features the biographies of the most notable individuals in various fields on an international level. He was the first researcher worldwide to publish studies on various therapies for the treatment of age-related macular degeneration (AMD), ocular ischemic syndrome, and various intraocular tumors, describing the first case of treatment with intravitreal Avastin for intraocular breast cancer metastases. He has also been a leading researcher in the diagnosis of intraocular tumors.

His professional interests also focus on vitreoretinal surgery, and he devotes much of his time to addressing surgical complications associated with retinal detachments, diabetic retinopathy, and diseases of the vitreoretinal interface.

He is a guest surgeon at national and international retinal surgery conferences, where he performs live surgeries to share with his colleagues the latest advances in the treatment of various retinal conditions.

He was recently appointed to the Editorial Board of the prestigious international journal “Journal of Ophthalmology”.

 

ACADEMIC BACKGROUND

He holds a Bachelor of Medicine from the Autonomous University of Barcelona (UAB) and is a specialist in ophthalmology.

Research Fellowship at the Mayo Clinic in Rochester, Minnesota (USA), in the Department of Retinal Diseases, Vitreoretinal Surgery, and Ocular Oncology.

IRB (Institutional Review Board) certified for research at the Mayo Clinic in Rochester, Minnesota.

 

ORGANIZATIONS TO WHICH HE BELONGS

Member of the Spanish Society of Ophthalmology.

Member of the American Academy of Ophthalmology.

Member of the Spanish Society of Retina and Vitreous.

Member of the European Association for Vision and Eye Research.

Member of the Association for Research in Vision and Ophthalmology (ARVO).

 

SCIENTIFIC PUBLICATIONS

1 – Cuesta-Lasso M, Vieira-Barros A, Dolz-Marco R, Roig-Revert MJ, Badal J, Amselem L, Díaz-Llopis M, Gallego-Pinazo R. Intravitreal therapies for non-neovascular age-related macular degeneration with intraretinal or subretinal fluid. Arch Soc Esp Oftalmol. 2017 Mar;92(3):101-106. doi: 10.1016 / j.oftal.2016.10.006. Epub 2016 Nov 29.

2 – Mansour AM, Arevalo JF, Badal J, Moorthy RS, Shah GK, Zegarra H, Pulido JS, Charbaji A, Amselem L, Lavaque AJ, Casella A, Ahmad B, Paschall JG, Caimi A, Staurenghi G. Paraproteinemic maculopathy. Ophthalmology. 2014 Oct;121(10):1925-32. doi: 10.1016/j.ophtha.2014.04.007.

3 – García-Arumí J, Amselem L, Gunduz K, Badal J, Adan A, Zapata MA, Valldeperas X, Huste F, Corcóstegui B. Photodynamic Therapy For Symptomatic Subretinal Fluid Related To Choroidal Nevus. Retina. 2012 Feb 23.

4- Amselem L, Gündüz K, Adan A, Karslιoğlu MZ, Rey A, Sabater N, Valldeperas X. Photodynamic Therapy of Symptomatic Choroidal Nevi. Middle East Afr J Ophthalmol. 2011 Oct;18(4):309-313.

5- Kaushik M, Pulido JS, Abreu R, Amselem L, Dispenzieri A. Ocular findings in patients with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes syndrome. Ophthalmology. 2011 Apr;118(4):778-82.

6 – Diago T, Amselem L, Pulido JS. Choroidal and Retinal Tumors in Adults. Choroidal Metastasis and Vascular Tumors of the Choroid. Cataract and Refractive Surgery Today . 2011. Epub 2011.

7 – Diago T, Amselem L, Pulido JS. Choroidal and Retinal Tumors in Adults. Intraocular Lymphoma, Retinal Astrocytoma, and Choroidal Osteoma. Cataract and Refractive Surgery Today. 2011. Epub 2011.

8 – Diago T, Amselem L, Pulido JS. Choroidal and Retinal Tumors in Adults. Choroidal Melanocytic Lesions. Cataract and Refractive Surgery Today. 2011. Epub 2011.

9- Diago T, Amselem L, Pulido JS. Vascular Tumors of the Retina in Adults. Vascular Tumors of the Retina. Cataract and Refractive Surgery Today. 2011. Epub 2011.

10 – Monés JM, Amselem L, Serrano A, Garcia M, Hijano M. Intravitreal ranibizumab for choroidal neovascularization secondary to pathologic myopia: 12-month results. Eye. 2009 Jun;23(6):1275-80; quiz 1281. Epub 2009 May 29.

11 – Montero, J; Cervera, E; Palomares, P; Amselem, L; Diaz-Llopis, M. Serous Retinal Detachment As A Presenting Feature of Chronic Myelogenous Leukemia Retinal Cases and Brief Reports. 2009, doi: 10.1097/ICB.0b013e3181b5ef71

12- Pinós J, Sabater A, Navarro G, Montero J, Amselem L, Carbonell P, Gonzalvo A. Pigmentary Glaucoma and Laser Iridotomy: Current Criteria and Indications. Studium Ophthalmologicum. 2009 – Vol. XXVII – N.º 2: 87-92.

13– Amselem L, Pulido JS, Gunduz K, García-Arumí J, Monés J. Infrared reflectance in choroidal melanomas and its correlation with fundus autofluorescence. Br J Ophthalmol. 2008 – Nov;92(11):1565-6.

14 – Amselem L, Diaz-Llopis M, Felipe A, Artigas JM , Navea A, García-Delpech S. Predictable Clinical Magnification and Residual Refraction After Intraocular Implantation of The IOL-Vip System in Patients With Macular Degeneration. Cataract Refract Surg. 2008 Sep;34(9):1571-7.

15- Amselem L, Diaz-Llopis M, Cervera E, Salom D, Montero J, Huste F. Pegaptanib sodium for acute retinal necrosis induced macular edema. Acta Ophthalmol Scand. 2008 2010 Mar;88(2):e42-3.

16 – Díaz-Llopis M, Montero J, Amselem L, Udaondo P, García-Delpech S. [Posterior chamber phakic intraocular lenses: a comparative study between ICL and PRL models. Choosing/selection criteria.] Arch Soc Esp Oftalmol. 2008 Apr;83(4):215-8.

17 – Amselem L, Diaz-Llopis M, Garcia-Delpech S, Montero J, Palomares P, Cervera E. Papulopustular eruption after intravitreal bevacizumab (Avastin). Acta Ophthalmol Scand. 2008 (2009 Feb;87(1):110-1.

18 – Amselem L, Díaz-Llopis M,Cervera E,García-Delpech S,Moratal-Peiro B,Palomares P. [Intravitreal injection of bevacizumab (Avastin(R)) for retinal angiomatous proliferation.] Arch Soc Esp Oftalmol. 2008 Jan;83(1):53-56.

19 – Amselem L, Pulido JS, Gunduz K, Bakri SJ, Diaz-Llopis M, Dolan JW, Morgan K, De Souza S, Link T, Rosvold J. Changes in fundus autofluorescence of choroidal melanomas following treatment. Eye. 2007 2009 Feb;23(2):428-34.

20 – Diaz-Llopis M, García-Delpech S, Salom D, Udaondo P, Bosch-Morell F, Quijada A, Romero FJ, Amselem L. High-dose infliximab prophylaxis in endotoxin-induced uveitis. J Ocul Pharmacol Ther. 2007 Aug;23(4):343-50.

21 – Díaz-Llopis M, Amselem L, Cervera E, García-Delpech S, Torralba C, Montero J. [Intravitreal injection of bevacizumab for pseudophakic cystoid macular edema resistant to steroids]. Arch Soc Esp Oftalmol. 2007 Jul;82(7):447-50.

22 – Palomares P, Amselem L, Diaz-Llopis M. Optical coherence tomography for diagnosis and monitoring of angle-closure glaucoma induced by topiramate. Can J Ophthalmol. 2007 Aug;42(4):633-4.

23 – Amselem L, Montero J, Diaz-Llopis M, Pulido JS, Bakri SJ, Garcia-Delpech S, Palomares P. Intravitreal Bevacizumab (Avastin) Injection in Ocular Ischemic Syndrome. Am J Ophthalmol. 2007 Jul;144(1):122-4.

24 – Gunduz K, Pulido JS, Bakri SJ, Amselem L, Petit-Fond E, Link T. Fundus Autofluorescence in Choroidal Melanocytic Lesions and Changes After Treatment. Trans Am Ophthalmol Soc. 2007. 2007;105:172-8; discussion 178-9.

25 – Diaz-Llopis M, Palomares P, Amselem L, Romero J, Garcia Delpech S. [Should we prescribe antioxidant drugs in ARMD patients?] Arch Soc Esp Oftalmol. 2007 Apr;82(4):195-6.

26 – Diaz-Llopis M, Amselem L, Romero FJ, García-Delpech S, Hernández ML. [Adalimumab therapy for Vogt-Koyanagi-Harada Syndrome]. Arch Soc Esp Oftalmol. 2007 Mar;82(3):131-2.

27 – Cervera E, Diaz-Llopis M, Salom D, Udaondo P,Amselem L. [Internal limiting membrane staining using intravitreal brilliant blue G: good help for vitreo-retinal surgeon in training.]. Arch Soc Esp Oftalmol. 2007 Feb;82(2):71-2.

28 – Amselem L, Pulido JS, Diaz-Llopis M, Cervera E, Montero J. Retinal Pigment Epithelial Tear Following Ranibizumab Use. Eye. 2007 Jun;21(6):846-7. Epub 2007 Jan 26.

29 – Amselem L, Cervera E, Diaz-Llopis M, Montero J, Garcia-Pous M, Udaondo P, Garcia-Delpech S, Salom D. Intravitreal bevacizumab (Avastin) for choroidal metastasis secondary to breast carcinoma: short-term follow-up. Eye. 2007 Apr;21(4):566-7. Epub 2006 Nov 24.

30 – Garcia-Pous M, Udaondo-Mirete P, Amselem-Gómez L, Salom-Alonso D, Cervera-Taulet E, Garcia-Delpech S, Diaz-Llopis M. [Spontaneous resolution of idiopathic macular hole type IV: optical coherence tomography follow-up]. Arch Soc Esp Oftalmol. 2006 Apr;81(4):229-32.

31 – Amselem-Gomez L, Garcia-Pous M, Udaondo-Mirete P et Al. Is it necessary the of an anaesthesiologist in the ophthalmologist operating room? Ocular Microsurgery. 2005; 13(1): 3-6

32 – Garcia-Pous M, Amselem-Gómez L, Udaondo-Mirete P et Al. Treatment of intracameral fibrinous membranes with tenecteplase, a new tissue plasminogen activator. Microcirugia ocular. 2005;13(1): 24-28

33 – Udaondo-Mirete P, Garcia-Pous M, Amselem-Gómez L et Al. Dry eye treatment: Lipolac® vs. Viscofresh 0.5%®. Ocular Microsurgery. 2005; 13(3): 78-81.

34 – Diaz Llopis M, Navea A, Peris C, Amselem L. et Al. Vogt-Koyanagi-Harada Syndrome. Actualization. Studium Ophthalmologicum. 2004.XXII (3):157-166.